These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1578318)

  • 1. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloxacillin absorption and disposition in cystic fibrosis.
    Spino M; Chai RP; Isles AF; Thiessen JJ; Tesoro A; Gold R; MacLeod SM
    J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of prednisone and prednisolone.
    Frey BM; Frey FJ
    Clin Pharmacokinet; 1990 Aug; 19(2):126-46. PubMed ID: 2199128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal model.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1988; 9(4):363-76. PubMed ID: 3207856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the anti-inflammatory agent tenidap on the pharmacokinetics and pharmacodynamics of prednisolone.
    Garg V; Blum R; Wilner KD; Jusko WJ
    J Clin Pharmacol; 1992 Mar; 32(3):222-30. PubMed ID: 1564126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of famotidine in patients with cystic fibrosis.
    Maish WA; McCubbin MM; Letzig LG; Farrar HC; Kearns GL
    J Clin Pharmacol; 1998 Nov; 38(11):1010-6. PubMed ID: 9824781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients].
    Repetto T; Marianelli L; Valenza T; Rosselli P; Messori A
    Pediatr Med Chir; 1985; 7(6):823-5. PubMed ID: 3837249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probenecid pharmacokinetics in cystic fibrosis.
    Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
    Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects.
    Schwartz JI; Mukhopadhyay S; Porras AG; Viswanathan-Aiyer KJ; Adcock S; Ebel DL; Gertz BJ
    J Clin Pharmacol; 2003 Feb; 43(2):187-92. PubMed ID: 12616672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
    Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC
    Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.
    Ferry JJ; Horvath AM; Bekersky I; Heath EC; Ryan CF; Colburn WA
    J Clin Pharmacol; 1988 Jan; 28(1):81-7. PubMed ID: 3350994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J; Smith IJ; Hilman BC; Wilson JT
    Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring glucocorticoid therapy: a pharmacokinetic approach.
    Hill MR; Szefler SJ; Ball BD; Bartoszek M; Brenner AM
    Clin Pharmacol Ther; 1990 Oct; 48(4):390-8. PubMed ID: 2225699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of single-dose doripenem in adults with cystic fibrosis.
    Cirillo I; Vaccaro N; Redman R; Black PL; Kearns GL
    J Clin Pharmacol; 2012 Nov; 52(11):1645-53. PubMed ID: 22174436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.